Valeo Pharma Inc. VPHIF
VPHIF Rating
VPHIF Rating Factors
VPHIF Company Overview
Valeo Pharma Inc. is a Canadian specialty pharmaceutical company focused on the commercialization of prescription products and select specialty healthcare brands in Canada. The company has operated primarily in the pharmaceuticals and healthcare distribution sectors, with an emphasis on respiratory, hospital specialty, neurology, and branded generics markets. Its business model historically centered on acquiring, licensing, and commercializing products from international pharmaceutical partners for the Canadian market rather than conducting large-scale in-house drug discovery.
The company’s principal revenue drivers have included sales from licensed and promoted pharmaceutical products across specialty therapeutic categories, supported by a national sales infrastructure targeting physicians, hospitals, and healthcare providers. Valeo built its positioning around access to Canadian commercialization expertise and an established specialty sales network. Public disclosures indicate the company expanded through licensing agreements and strategic partnerships with global pharmaceutical developers. Valeo Pharma was founded in Canada and evolved from a specialty commercialization platform into a broader branded pharmaceutical business serving the Canadian healthcare market.
VPHIF Income Statement
VPHIF Balance Sheet
VPHIF Price History
VPHIF Valuation
VPHIF Dividends and Shares
VPHIF Corporate Info
Kirkland, QC H9H 4R9